Início › Câncer de Pâncreas › Maryland › Baltimore
Ensaios clínicos de Câncer de Pâncreas em Baltimore, MD
31 estudos para Câncer de Pâncreas estão buscando participantes em locais em Baltimore e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 2
- Johns Hopkins University, Baltimore
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RecrutandoFase 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecrutandoFase 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- e mais 1
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecrutandoFase 3
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecrutandoFase 3
- University of Maryland School - Division of Hematology/Oncology, Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecrutandoFase 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RecrutandoEstudo observacional
- The Johns Hopkins University School of Medicine, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- Johns Hopkins, Baltimore
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RecrutandoFase 2
- Johns Hopkins Hospital, Baltimore
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RecrutandoEstudo observacional
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Recrutando
- Johns Hopkins Hospital, Baltimore
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RecrutandoFase 2
- Johns Hopkins University, Baltimore
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecrutandoFase 3
- Sinai Hospital of Baltimore, Baltimore
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Johns Hopkins Hospital, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
RecrutandoFase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- John Hopkins University, Baltimore
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
RecrutandoFase 1Voluntários saudáveis bem-vindos
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecrutandoFase 1/2
- Johns Hopkins Hospital, Baltimore
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecrutandoFase 3
- Sinai Hospital of Baltimore, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Johns Hopkins University, Baltimore
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
RecrutandoFase 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Johns Hopkins University, Baltimore
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
RecrutandoEstudo observacional
- The Johns Hopkins Hospital, Baltimore
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecrutandoFase 2
- Ohio State University-Telemedicine, Baltimore
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
RecrutandoFase 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · a 8 mi de distância
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecrutandoFase 3
- Johns Hopkins Hospital, Baltimore
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RecrutandoEstudo observacional
- The Johns Hopkins Hospital, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
RecrutandoFase 1/2
- Johns Hopkins, Baltimore
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RecrutandoEstudo observacional
- Johns Hopkins Hospital, Baltimore
Ensaios de Câncer de Pâncreas em outras cidades
- Houston, TX61 estudos
- New York City, NY60 estudos
- Boston, MA43 estudos
- Nashville, TN39 estudos
- Los Angeles, CA35 estudos
- St. Louis, MO33 estudos
- Arlington, VA33 estudos
- San Antonio, TX31 estudos
- Philadelphia, PA26 estudos
- Tampa, FL26 estudos
- Durham, NC24 estudos
- San Diego, CA24 estudos
Outros estudos em Baltimore
- Câncer de Pulmão de Não Pequenas Células60 estudos
- Câncer de Mama47 estudos
- Câncer de Próstata43 estudos
- Câncer de Pulmão40 estudos
- Câncer (todos os tipos)37 estudos
- Câncer Colorretal31 estudos
- Câncer Metastático28 estudos
- Obesidade26 estudos
- Câncer de Bexiga24 estudos
- Insuficiência Cardíaca24 estudos
- Câncer de Ovário22 estudos
- Acidente Vascular Cerebral21 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.